Health Inequities in Manitoba: Is the Socioeconomic Gap
Health Inequities in Manitoba: Is the Socioeconomic Gap
Health Inequities in Manitoba: Is the Socioeconomic Gap
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Health</strong> <strong>Inequities</strong> <strong>in</strong> <strong>Manitoba</strong>: <strong>Is</strong> <strong>the</strong> <strong>Socioeconomic</strong> <strong>Gap</strong> <strong>in</strong> <strong>Health</strong> Widen<strong>in</strong>g or Narrow<strong>in</strong>g Over Time?<br />
Chapter 8: Pharmaceutical Use<br />
Post-Acute Myocardial Infarction (AMI) Care: Beta-Blocker Prescrib<strong>in</strong>g<br />
Def<strong>in</strong>ition<br />
Beta–blockers, properly known as beta–adrenergic block<strong>in</strong>g drugs, have been shown to lower <strong>the</strong> risk<br />
of subsequent heart attacks after patients have suffered an AMI.<br />
Def<strong>in</strong>ition: <strong>the</strong> proportion of patients aged 20 and older hospitalized for Acute Myocardial Infarction<br />
(ICD–9 CM code 410; ICD–10 code I21) who filled at least one prescription for a beta–blocker (ATC<br />
C07AA, C07AB) with<strong>in</strong> four months of <strong>the</strong>ir AMI.<br />
Patients with a diagnosis of asthma, COPD, or peripheral vascular disease were excluded because beta–<br />
blockers are contra–<strong>in</strong>dicated for those patients. Patients with a hospitalization for AMI <strong>in</strong> <strong>the</strong> preced<strong>in</strong>g<br />
three years were also excluded to remove those experienc<strong>in</strong>g multiple heart attacks <strong>in</strong> a relatively short<br />
period.<br />
Exclusions for contra–<strong>in</strong>dications:<br />
• asthma, ICD–9–CM code 493; ICD–10–CA code J45<br />
• chronic obstructive pulmonary disease, ICD–9–CM codes 491 and 492; ICD–10–CA codes J41–<br />
J44<br />
• peripheral vascular disease, ICD–9–CM codes 443 and 459; ICD–10–CA codes I73, I79.2, I87<br />
NOTE: Up until <strong>the</strong> year 2005, nor<strong>the</strong>rn First Nations community pharmaceutical data may be miss<strong>in</strong>g<br />
due to lack of prescription data be<strong>in</strong>g entered <strong>in</strong>to <strong>the</strong> DPIN system. However, as of 2005 to <strong>the</strong> present,<br />
prescriptions for First Nations communities are dispensed through a private pharmaceutical company<br />
that reports all prescriptions through DPIN.<br />
Time Periods Percentage of patients post-AMI with beta-blocker prescription<br />
T1: 1996/97-1998/99 65.28<br />
T2: 1999/00-2001/02 75.92<br />
T3: 2002/03-2004/05 80.58<br />
T4: 2005/06-2007/08 81.28<br />
Key F<strong>in</strong>d<strong>in</strong>gs: Post-Acute Myocardial Infarction (AMI) Care: Beta-Blocker Prescrib<strong>in</strong>g<br />
<strong>Manitoba</strong> overall rates:<br />
• From <strong>the</strong> first time period T1 (1996/97-1998/99) to <strong>the</strong> last time period T4 (2005/06-2007/08), <strong>the</strong><br />
percentage of patients with an AMI who filled at least one prescription for a beta-blocker with<strong>in</strong> four<br />
months of <strong>the</strong>ir AMI <strong>in</strong>creased from 65.3% to 81.3% prov<strong>in</strong>cially.<br />
<strong>Manitoba</strong> Centre for <strong>Health</strong> Policy 165